다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Antiviral research, v.96 no.2, 2012년, pp.196 - 202
De Leo, A. , Arena, G. , Lacanna, E. , Oliviero, G. , Colavita, F. , Mattia, E.
AI-Helper
Resveratrol (RV), a polyphenolic natural product present in many plants and fruits, exhibits anti-inflammatory, cardio-protective and anti-proliferative properties. Moreover, RV affects a wide variety of viruses including members of the Herpesviridae family, retroviruses, influenza A virus and polyo...
Rev Med Virol Amon 15 149 2005 10.1002/rmv.456 Reactivation of Epstein-Barr virus from latency
Biochim Biophys Acta Angel 1072 129 1991 The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
J Exp Clin Cancer Res Berardi 28 96 2009 10.1186/1756-9966-28-96 Resveratrol exhibits a strong cytotoxic activity in cultured cells and has an antiviral action against polyomavirus: potential clinical use
Antioxid Redox Signal Bhat 3 1041 2001 10.1089/152308601317203567 Biological effects of resveratrol
J Biol Chem Borra 280 17187 2005 10.1074/jbc.M501250200 Mechanism of human SIRT1 activation by resveratrol
Biochem Soc Trans Campagna 2010 10.1042/BST0380050 Antiviral activity of resveratrol
J Virol Cayrol 69 4206 1995 10.1128/jvi.69.7.4206-4212.1995 Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1
Molecular cancer research: MCR De Leo 9 1346 2011 10.1158/1541-7786.MCR-11-0145 Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt’s lymphoma cells depending on viral latency program
Expert Opin Ther Pat De Paoli 20 807 2010 10.1517/13543771003796590 Epstein-Barr virus: novel patented therapeutics
Antiviral Res Docherty 67 155 2005 10.1016/j.antiviral.2005.06.008 Effect of resveratrol on herpes simplex virus vaginal infection in the mouse
Antiviral Res Docherty 72 171 2006 10.1016/j.antiviral.2006.07.004 Resveratrol inhibition of varicella-zoster virus replication in vitro
PLoS ONE Dyson 7 e33364 2012 10.1371/journal.pone.0033364 Resveratrol inhibits KSHV reactivation by lowering the levels of cellular EGR-1
Antiviral Res Evers 63 85 2004 10.1016/j.antiviral.2004.03.002 3,4′,5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling
Antiviral Res Faith 72 242 2006 10.1016/j.antiviral.2006.06.011 Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells
New Microbiol Gaeta 32 333 2009 Diagnosis of neurological herpesvirus infections: real time PCR in cerebral spinal fluid analysis
Biol Trace Elem Res Gargouri 144 1449 2011 10.1007/s12011-011-9135-5 Reactive oxygen species production and antioxidant enzyme expression after Epstein-Barr virus lytic cycle induction in Raji cell line
N Engl J Med Greenspan 313 1564 1985 10.1056/NEJM198512193132502 Replication of Epstein-Barr virus within the epithelial cells of oral “hairy” leukoplakia, an AIDS-associated lesion
J Virol Hong 79 13993 2005 10.1128/JVI.79.22.13993-14003.2005 Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model
J Virol Hsu 82 3679 2008 10.1128/JVI.02301-07 Epstein-Barr Virus Lytic Transactivator Zta Enhances Chemotactic Activity through Induction of Interleukin-8 in Nasopharyngeal Carcinoma Cells
Int J Cancer Jones 121 1274 2007 10.1002/ijc.22839 Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease
Biochem Pharmacol Kundu 72 1506 2006 10.1016/j.bcp.2006.08.005 Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets
Annu Rev Pathol Kutok 1 375 2006 10.1146/annurev.pathol.1.110304.100209 Spectrum of Epstein-Barr virus-associated diseases
Biol Trace Elem Res Lassoued 137 13 2010 10.1007/s12011-009-8555-y Transcription of the Epstein-Barr virus lytic cycle activator BZLF-1 during oxidative stress induction
Semin Cancer Biol Lin 13 107 2003 10.1016/S1044-579X(02)00128-1 NF-kappaB in cancer: a marked target
J Virol Ma 85 165 2011 10.1128/JVI.01512-10 A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas
J Gen Virol Mahot 84 965 2003 10.1099/vir.0.18845-0 A novel function for the Epstein-Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene
J Immunol Manna 164 6509 2000 10.4049/jimmunol.164.12.6509 Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation
J Immunol Martin 145 1859 1990 10.4049/jimmunol.145.6.1859 Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis
Mol Cancer Matusali 8 18 2009 10.1186/1476-4598-8-18 Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds
J Exper Med Miyazaki 178 439 1993 10.1084/jem.178.2.439 Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus
J Infect Dis Palamara 191 1719 2005 10.1086/429694 Inhibition of influenza A virus replication by resveratrol
Front Biosci (Schol Ed) Ralhan 1 45 2009 10.2741/s6 Nuclear factor-kappa B links carcinogenic and chemopreventive agents
Rickinson 2007 Epstein Barr Virus
Biochem J Saatian 393 657 2006 10.1042/BJ20050791 Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells
Cancer Metastasis Rev Shu 29 483 2010 10.1007/s10555-010-9239-y Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis
PLoS ONE Villa-Cuesta 6 e29513 2011 10.1371/journal.pone.0029513 Resveratrol Inhibits Protein Translation in Hepatic Cells
Mini Rev Med Chem Villegas 10 914 2010 10.2174/138955710792007150 New strategies and patent therapeutics in EBV-associated diseases
Nutr Cancer Whitlock 2012 10.1080/01635581.2012.667862 The anticancer effects of Resveratrol: modulation of transcription factors
J Virol Wu 78 4847 2004 10.1128/JVI.78.9.4847-4865.2004
Molecules Yiu 15 7115 2010 10.3390/molecules15107115 Inhibitory effects of resveratrol on the Epstein-Barr virus lytic cycle
J Cell Biochem Yu 113 752 2012 10.1002/jcb.23431 Cellular and molecular effects of resveratrol in health and disease
Embo J Zabel 12 201 1993 10.1002/j.1460-2075.1993.tb05646.x Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus
Life Sci Zhang 85 484 2009 10.1016/j.lfs.2009.07.014 Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD+-dependent SIRT1 activity
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.